Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oxidation inhibits amyloid fibril formation of transthyretin.

The FEBS journal - 1 Dec 2006

Maleknia Simin D, Reixach Natàlia, Buxbaum Joel N

Abstract excerpt

The role of amino acid side chain oxidation in the formation of amyloid assemblies has been investigated. Chemical oxidation of amino acid side chains has been used as a facile method of introducing mutations on protein structures. Oxidation promotes changes within tertiary contacts that enable identification of residues and interactions critical in stabilizing protein structures. Transthyretin (TTR) is a soluble...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Amyloid
Share to Kinetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Spectrometry

Share to Molecular Sequence Data

Share to Oxidation-Reduction

Share to Prealbumin

Share to Protein Folding

Source

Identifiers

PMID: 17116243
DOI: 10.1111/j.1742-4658.2006.05532.x

Genes

TTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oxidation inhibits amyloid fibril formation of transthyretin.PMID 17116243Read ↗

Mass spectrometry footprinting reveals how kinetic stabilizers counteract transthyretin dynamics altered by pathogenic mutations.Semantic proximity Read ↗

Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice?Semantic proximity Read ↗

Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.Semantic proximity Read ↗

Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation.Semantic proximity Read ↗

Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met.Semantic proximity Read ↗

Protein subunit interactions and structural integrity of amyloidogenic transthyretins: evidence from electrospray mass spectrometry.Semantic proximity Read ↗

Trans-suppression of misfolding in an amyloid disease.Semantic proximity Read ↗

Impact of age and amyloidosis on thiol conjugation of transthyretin in hereditary transthyretin amyloidosis.Semantic proximity Read ↗

Structure-based probe reveals the presence of large transthyretin aggregates in plasma of ATTR amyloidosis patientsSemantic proximity Read ↗

The importance of a gatekeeper residue on the aggregation of transthyretin: implications for transthyretin-related amyloidoses.Semantic proximity Read ↗

In Vitro and in Vivo Interactions of Homocysteine with Human Plasma TransthyretinSemantic proximity Read ↗

Transthyretin monomers: a new plasma biomarker for pre-symptomatic transthyretin-related amyloidosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.